Diagnostic parameters detected in treatment (A) and non-treatment (B) groups at baseline (T0), 10 days (T1), and 30 days after the start of the treatment (T2).
| Diagnostic parameters . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | ||||
|---|---|---|---|---|---|---|
| . | T0 . | T1 . | T2 . | T0 . | T1 . | T2 . |
| Amsel criteria | ||||||
| Homogenous vaginal discharge | 60 | 5 | 6 | 19 | 16 | 17 |
| Clue cell presence | 58 | 3 | 0 | 17 | 14 | 13 |
| Positive amine test | 60 | 2 | 0 | 18 | 13 | 17 |
| Vaginal pH > 4.5 | 60 | 2 | 0 | 17 | 16 | 18 |
| Nugent score | ||||||
| 0–3 | 0 | 58 | 60 | 0 | 0 | 0 |
| 4–6 | 0 | 2 | 0 | 1 | 11 | 4 |
| 7–10 | 60 | 0 | 0 | 19 | 9 | 16 |
| Lactobacillary grade | ||||||
| I | 0 | 59 | 60 | 0 | 0 | 0 |
| II | 0 | 1 | 0 | 0 | 2 | 0 |
| III | 60 | 0 | 0 | 20 | 18 | 20 |
| Diagnostic parameters . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | ||||
|---|---|---|---|---|---|---|
| . | T0 . | T1 . | T2 . | T0 . | T1 . | T2 . |
| Amsel criteria | ||||||
| Homogenous vaginal discharge | 60 | 5 | 6 | 19 | 16 | 17 |
| Clue cell presence | 58 | 3 | 0 | 17 | 14 | 13 |
| Positive amine test | 60 | 2 | 0 | 18 | 13 | 17 |
| Vaginal pH > 4.5 | 60 | 2 | 0 | 17 | 16 | 18 |
| Nugent score | ||||||
| 0–3 | 0 | 58 | 60 | 0 | 0 | 0 |
| 4–6 | 0 | 2 | 0 | 1 | 11 | 4 |
| 7–10 | 60 | 0 | 0 | 19 | 9 | 16 |
| Lactobacillary grade | ||||||
| I | 0 | 59 | 60 | 0 | 0 | 0 |
| II | 0 | 1 | 0 | 0 | 2 | 0 |
| III | 60 | 0 | 0 | 20 | 18 | 20 |
Diagnostic parameters detected in treatment (A) and non-treatment (B) groups at baseline (T0), 10 days (T1), and 30 days after the start of the treatment (T2).
| Diagnostic parameters . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | ||||
|---|---|---|---|---|---|---|
| . | T0 . | T1 . | T2 . | T0 . | T1 . | T2 . |
| Amsel criteria | ||||||
| Homogenous vaginal discharge | 60 | 5 | 6 | 19 | 16 | 17 |
| Clue cell presence | 58 | 3 | 0 | 17 | 14 | 13 |
| Positive amine test | 60 | 2 | 0 | 18 | 13 | 17 |
| Vaginal pH > 4.5 | 60 | 2 | 0 | 17 | 16 | 18 |
| Nugent score | ||||||
| 0–3 | 0 | 58 | 60 | 0 | 0 | 0 |
| 4–6 | 0 | 2 | 0 | 1 | 11 | 4 |
| 7–10 | 60 | 0 | 0 | 19 | 9 | 16 |
| Lactobacillary grade | ||||||
| I | 0 | 59 | 60 | 0 | 0 | 0 |
| II | 0 | 1 | 0 | 0 | 2 | 0 |
| III | 60 | 0 | 0 | 20 | 18 | 20 |
| Diagnostic parameters . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | ||||
|---|---|---|---|---|---|---|
| . | T0 . | T1 . | T2 . | T0 . | T1 . | T2 . |
| Amsel criteria | ||||||
| Homogenous vaginal discharge | 60 | 5 | 6 | 19 | 16 | 17 |
| Clue cell presence | 58 | 3 | 0 | 17 | 14 | 13 |
| Positive amine test | 60 | 2 | 0 | 18 | 13 | 17 |
| Vaginal pH > 4.5 | 60 | 2 | 0 | 17 | 16 | 18 |
| Nugent score | ||||||
| 0–3 | 0 | 58 | 60 | 0 | 0 | 0 |
| 4–6 | 0 | 2 | 0 | 1 | 11 | 4 |
| 7–10 | 60 | 0 | 0 | 19 | 9 | 16 |
| Lactobacillary grade | ||||||
| I | 0 | 59 | 60 | 0 | 0 | 0 |
| II | 0 | 1 | 0 | 0 | 2 | 0 |
| III | 60 | 0 | 0 | 20 | 18 | 20 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
